Target Name: SH2D4A
NCBI ID: G63898
Other Name(s): Protein phosphatase 1 regulatory subunit 38 | SH2 domain containing 4A | SH2 domain-containing protein 4A | SH2 domain containing 4A, transcript variant 1 | SH24A_HUMAN | SH2D4A variant 1 | protein phosphatase 1 regulatory subunit 38 | FLJ20967 | protein SH(2)A | SH2A | SH2 domain-containing protein 4A (isoform a) | Protein SH(2)A | PPP1R38

SH2D4A: A Potential Drug Target and Biomarker for Protein Phosphatase 1 Regulation

Protein phosphatase 1 (PP1) is a key regulator of protein kinase (PK) activity and is involved in various cellular processes, including cell signaling, DNA replication, and stress response. The SH2D4A protein, a regulatory subunit of PP1, has been identified as a potential drug target and biomarker for various diseases.

The SH2D4A protein is a 21-kDa protein that is expressed in various cell types, including neurons, muscle cells, and cancer cells. It is a key component of the PP1 complex, which includes the regulatory subunits SH2, SH3, and SH4. SH2D4A protein plays a crucial role in the regulation of PP1 activity and is involved in the formation of the active form of PP1, which is required for protein kinase activity.

The SH2D4A protein has been shown to be involved in various cellular processes, including cell signaling, DNA replication, and stress response. For example, SH2D4A has been shown to be involved in the regulation of cell proliferation, and has been shown to interact with the protein p21 (transforming growth factor-尾1). This interaction between SH2D4A and p21 has been shown to play a role in the regulation of cell cycle progression and the inhibition of apoptosis.

In addition to its role in PP1 regulation, the SH2D4A protein has also been shown to be involved in the regulation of protein function. For example, SH2D4A has been shown to interact with the protein syntaxin, which is involved in the regulation of microtubule dynamics. This interaction between SH2D4A and syntaxin has been shown to play a role in the regulation of protein localization and stability.

The potential drug target for SH2D4A is the regulation of PP1 activity, which is involved in the regulation of a wide range of cellular processes, including cell signaling, DNA replication, and stress response. The SH2D4A protein has been shown to play a crucial role in the regulation of PP1 activity, and targeting this protein has the potential to be a valuable drug target for various diseases.

One of the key challenges in the development of SH2D4A as a drug target is its expression and stability in the body. SH2D4A is a 21-kDa protein, which is relatively small and does not have a well-defined function in the body. This makes it difficult to study the protein in the body and to determine its efficacy as a drug. However, efforts are being made to overcome this challenge, and various researchers are studying the expression and stability of SH2D4A in various cell types and organisms.

Another challenge in the development of SH2D4A as a drug target is its role in the regulation of PP1 activity. PP1 is involved in the regulation of a wide range of cellular processes, including cell signaling, DNA replication, and stress response. This makes it difficult to study the protein and to determine its efficacy as a drug. However, efforts are being made to overcome this challenge, and various researchers are studying the regulation of PP1 activity and the role of SH2D4A in this process.

In conclusion, SH2D4A is a protein that has been shown to be involved in various cellular processes, including cell signaling, DNA replication, and stress response. The SH2D4A protein has also been shown to play a crucial role in the regulation of PP1 activity, which is involved in the regulation of a wide range of cellular processes. The potential drug target for SH2D4A is the regulation of PP1 activity, and targeting this protein has the potential to be a valuable drug for various diseases. Further research is needed to study the expression and stability of SH2D4A in the body and to determine its efficacy as a drug.

Protein Name: SH2 Domain Containing 4A

Functions: Inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. May play a role in T-cell development and function

More Common Targets

SH2D4B | SH2D5 | SH2D6 | SH2D7 | SH3 domain-binding protein 1 | SH3BGR | SH3BGRL | SH3BGRL2 | SH3BGRL3 | SH3BP1 | SH3BP2 | SH3BP4 | SH3BP5 | SH3BP5-AS1 | SH3BP5L | SH3D19 | SH3D21 | SH3GL1 | SH3GL1P1 | SH3GL1P2 | SH3GL1P3 | SH3GL2 | SH3GL3 | SH3GLB1 | SH3GLB2 | SH3KBP1 | SH3PXD2A | SH3PXD2A-AS1 | SH3PXD2B | SH3RF1 | SH3RF2 | SH3RF3 | SH3RF3-AS1 | SH3TC1 | SH3TC2 | SH3TC2-DT | SH3YL1 | SHANK1 | SHANK2 | SHANK2-AS1 | SHANK2-AS3 | SHANK3 | SHARPIN | SHB | SHBG | SHC1 | SHC2 | SHC3 | SHC4 | SHCBP1 | SHCBP1L | SHD | SHE | SHF | SHFL | SHH | SHISA2 | SHISA3 | SHISA4 | SHISA5 | SHISA6 | SHISA7 | SHISA8 | SHISA9 | SHISAL1 | SHISAL2A | SHISAL2B | SHKBP1 | SHLD1 | SHLD2 | SHLD2P1 | SHLD2P3 | SHLD3 | SHMT1 | SHMT2 | SHOC1 | SHOC2 | Short transient receptor potential channel (TrpC) | SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10